Skip to main content
Quest Diagnostics Home

Lab Testing for Overlapping Rheumatic Diseases: A Comprehensive Approach

Presented by Dr Ara H. Dikranian, moderated by Dr Ann E. Salm

On demand WEBINAR

Thursday, November 18, 2021

 

The objectives of this webinar include:

•  Review background, epidemiology, and language of rheumatic disease overlap

•  Present/review relevant guidelines for rheumatic disease diagnosis

•  Assess an innovative panel of relevant biomarkers for diagnosing rheumatic diseases

•  Review case study of patients with overlapping symptoms and clinical application of relevant biomarkers

•  Q&A

Ara H. Dikranian, MD, Rheumatologist, Cabrillo Center for Rheumatic Disease, San Diego, CA

Moderated by: Ann E. Salm, PhD, MS, M(ASCP), Director, Medical Science Liaison, Infectious Diseases/Immunology, Quest Diagnostics

Ara H. Dikranian, MD                                                                                                                                            
Ann E. Salm, PhD, MS, M(ASCP)                                                                                           

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2023 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.